Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
暂无分享，去创建一个
W. Weichert | P. Schirmacher | A. Stenzinger | D. Kazdal | J. Budczies | T. Hielscher | A. Krämer | M. Kirchner | V. Endris | T. Bochtler | L. Heukamp | M. Allgäuer | H. Löffler | O. Neumann | A. Volckmar | J. Leichsenring | Anna Reiling